Mirum Pharmaceuticals Inc (MIRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 222,503 | 222,969 | 233,245 | 302,843 | 286,326 |
| Marketable Securities | 57,812 | 61,476 | 45,126 | N/A | N/A |
| Receivables | 78,286 | 68,530 | 60,430 | 54,999 | 67,968 |
| Inventories | 22,403 | 21,594 | 20,438 | 21,606 | 22,312 |
| TOTAL | $392,788 | $386,626 | $367,829 | $389,465 | $387,541 |
| Non-Current Assets | |||||
| PPE Net | 1,139 | 1,212 | 1,101 | 501 | 706 |
| Investments And Advances | 12,526 | 9,321 | 17,075 | 0 | 0 |
| Intangibles | 249,819 | 255,794 | 261,768 | 257,443 | 252,925 |
| Other Non-Current Assets | 14,482 | 14,940 | 12,981 | 4,553 | 5,449 |
| TOTAL | $277,966 | $281,267 | $292,925 | $262,497 | $259,080 |
| Total Assets | $670,754 | $667,893 | $660,754 | $651,962 | $646,621 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 14,618 | 9,545 | 9,842 | 15,983 | 7,416 |
| Accrued Expenses | 111,933 | 104,700 | 101,394 | 89,568 | 78,544 |
| TOTAL | $126,551 | $115,751 | $112,308 | $105,909 | $87,064 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 318,563 | 320,118 | 319,458 | 311,450 | 310,887 |
| TOTAL | $318,563 | $320,118 | $319,458 | $311,450 | $310,887 |
| Total Liabilities | $445,114 | $435,869 | $431,766 | $417,359 | $397,951 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 49,014 | 48,005 | 47,707 | 47,133 | 47,003 |
| Common Shares | 5 | 5 | 5 | 5 | 5 |
| Retained earnings | -644,181 | -620,391 | -606,156 | -581,518 | -556,239 |
| Other shareholders' equity | -373 | 920 | -477 | -13 | 1,644 |
| TOTAL | $225,640 | $232,024 | $228,988 | $234,603 | $248,670 |
| Total Liabilities And Equity | $670,754 | $667,893 | $660,754 | $651,962 | $646,621 |